Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.
Find an article or report by keywords:
P T 2009;34(7):389-390
Prophylaxis is imperative for Pneumocystis pneumonia (PCP), an important cause of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection. Despite the availability of well-known prophylaxis guidelines and highly active antiretroviral treatment (HAART), PCP remains a leading opportunistic infection and an AIDS-defining diagnosis.1 Several antimicrobial agents are effective as prophylaxis against this organism, and prescribing differences are largely influenced by reports of allergies.